Literature DB >> 1537465

Characterization of human cytochrome P450 enzymes.

F P Guengerich1.   

Abstract

Many biochemical approaches have been applied to the human cytochrome P450 enzymes, and more than 20 different gene products have been characterized with regard to their properties and catalytic specificities. The complement of the various cytochrome P450 enzymes in a given individual varies markedly, and dramatic differences may be seen in drug metabolism, pharmacological response, and susceptibility to toxic effects. An understanding of the nature of the individual cytochrome P450 enzymes and their regulation should be useful in determining the most suitable animal models, ascertaining risk from chemicals, and in avoiding undesirable drug interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537465     DOI: 10.1096/fasebj.6.2.1537465

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  26 in total

1.  Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.

Authors:  F De Rienzo; F Fanelli; M C Menziani; P G De Benedetti
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

Review 2.  The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors:  H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

3.  Association of GSTs polymorphisms with risk of gestational diabetes mellitus.

Authors:  Yan Li; Shaoru Li; Qianqian Zhai; Jie Hai; Di Wang; Meng Cao; Qinggui Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam.

Authors:  J Ahonen; K T Olkkola; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

Review 5.  Towards quantitative prediction of oral drug absorption.

Authors:  Jennifer B Dressman; Kirstin Thelen; Ekarat Jantratid
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 6.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 7.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  M T Kinirons; P Crome
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

8.  Cruciferous vegetables and drug metabolism.

Authors:  J R Schein
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

Review 9.  Cytochrome P450-mediated estrogen catabolism therapeutic avenues in epilepsy.

Authors:  Megha Gautam; Ganesh Thapa
Journal:  Acta Neurol Belg       Date:  2020-08-02       Impact factor: 2.396

10.  Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.

Authors:  Ehab S Eldesoky; Sherif I Kamel; Ahlam M Farghaly; Madiha Y Bakheet; Mohsen A Hedaya; Jean-Pascal Siest
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.